Neauvia Stimulate is a CE-marked injectable dermal filler developed for professional aesthetic treatments. The product combines immediate volumising properties with long-term biostimulation, supporting skin structure and quality over time. Its formulation is based on a combination of cross-linked hyaluronic acid and calcium hydroxyapatite (CaHA), both widely used and well-documented materials in aesthetic medicine.
The hyaluronic acid is cross-linked using PEG (polyethylene glycol) IPN technology, designed to provide structural support and hydration within the mid to deep dermal layers. Calcium hydroxyapatite microspheres contribute to tissue support and are known to stimulate collagen production as part of the body’s natural regenerative response.
Neauvia Stimulate has a homogeneous, cohesive gel consistency that allows controlled injection, even distribution in the tissue, and natural-looking correction without excessive rigidity. The product is designed to adapt well to facial movements and maintain shape stability after implantation.
Neauvia Stimulate is intended for use in adult patients as part of aesthetic procedures aimed at improving skin quality and facial contours. Typical treatment goals include:
- restoration of soft tissue volume
- improvement of skin firmness and elasticity
- reduction in the appearance of moderate to deep wrinkles and folds
- support of facial contours affected by age-related volume loss
- improvement of skin texture and overall appearance
The treatment may result in:
- immediate volumising effects due to the hyaluronic acid component
- gradual improvement in skin structure over time through collagen stimulation
- smoother skin surface and more defined facial contours
Neauvia Stimulate can be used on various areas such as the cheeks, cheekbones, chin, jawline, neck, and décolleté. Treatment protocols, injection depth, and session intervals are determined exclusively by the treating medical professional based on individual patient needs. Effects may persist for up to 12 months, depending on patient-specific factors and treatment technique.